Indications
Cholib is indicated as adjunctive therapy to diet and exercise in high cardiovascular risk adult patients with mixed dyslipidaemia to reduce triglycerides and increase HDL C levels when LDL C levels are adequately controlled with the corresponding dose of simvastatin monotherapy.
Composition
- Active substance
- fenofibrate, simvastatin
- International name (INN)
- fenofibrate;simvastatin
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Cholib
- Active substance
- fenofibrate, simvastatin
- ATC code
- C10BA04
- Therapeutic area
- Dyslipidemias